Which Form of NAD+ Absorbs More Efficiently in Dogs: Chews or Powder?

By Michael Astor, DVM

✓ Medically reviewed by Michael Astor, DVM — August 13, 2026 For general education — not a substitute for veterinary care.

Comparisons · August 29, 2026 · 7 min read

My call up front: powder wins on absorption predictability, but only if your dog actually eats the food it's mixed into.

A 68-pound Labrador named Otis, ten years old, had started taking the stairs to his owner’s bedroom one at a time instead of two, and he’d stopped meeting her at the door with the same enthusiasm he’d had at eight. She’d read about NAD+ precursors for senior dogs and asked me the question I now hear almost weekly: chew or powder, which one actually gets absorbed?

I want to give you my answer before I walk through the reasoning, because that’s how I’d want a clinician to talk to me. Powder mixed into food is the more predictable absorption vehicle for NAD+ precursors like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) — not because a dog’s mouth does anything special to a chew, but because powder is easier to dose accurately, mixes evenly with a meal that buffers stomach acid, and avoids the moisture-and-heat exposure that soft chews go through during manufacturing, which can degrade a moisture-sensitive precursor before the dog ever eats it. Chews still have a real place in this decision. I’ll get to why.

What NAD+ Precursors Actually Are, and Why the Gut Is the Bottleneck

Neither NR nor NMN is absorbed as itself in any meaningful sense once it’s inside a mammalian digestive tract. The gut and liver are aggressive about breaking these molecules down before they ever reach systemic circulation. A frequently cited Nicotinamide riboside is uniquely and orally bioavailable in mice and humans study found that oral NR is absorbed and produces dose-dependent increases in the blood NAD+ metabolome at single doses of 100, 300, and 1,000 mg — but the pathway isn’t a clean, direct one. NR is substantially hydrolyzed to nicotinamide (NAM) in the gastrointestinal tract and liver before contributing to NAD+ synthesis through the salvage pathway. That’s first-pass metabolism doing what first-pass metabolism does: it doesn’t care whether the precursor arrived as a chewed treat or a spoonful of powder stirred into kibble. It cares about gut transit time, gastric pH exposure, and how much of the compound survives intact long enough to be taken up.

This is where the chew-versus-powder question actually gets interesting, and where most marketing copy stops being useful.

The Myth: Chewing Releases the Precursor Faster

The intuitive assumption — that mechanically breaking down a chew in the mouth “activates” it faster than powder stirred into food — doesn’t hold up against what we know about how these molecules move through a dog’s digestive tract. Mastication in dogs is brief and incomplete by design; most kibble and soft chews are swallowed in large fragments, not pulverized. Whatever surface-area advantage chewing might theoretically confer is minor compared to what happens over the next twenty to sixty minutes in the stomach and small intestine, where the real hydrolysis and transport occur. The Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults trial, run in humans on a dosage form closer to a swallowed tablet than a chewed treat, still documented consistent elevation of NAD+ metabolites — evidence that the delivery format itself isn’t the primary lever on outcome. What is the lever: dose consistency, formulation stability, and whether the dog actually finishes the dose.

A Pattern I’ve Watched Repeat in Exam Rooms

I had a case a few years back that’s stuck with me because it illustrates the real failure point better than any pharmacokinetics chart. A twelve-year-old spayed female mixed breed, low fifties in body weight, came in for a senior workup in early spring. Her owner had started her on a powder-form NAD+ precursor stirred into a wet-food topper about six weeks prior, hoping to support her cognition and energy. Within the first ten days the dog developed intermittent loose stool and started leaving food in the bowl — not vomiting, just picking at meals she used to finish. The owner, understandably, assumed the supplement was the problem and had nearly stopped it before our visit. What we found on history was simpler: she’d increased the topper volume faster than the label’s titration schedule recommended, and the GI upset was a dosing-ramp issue, not a format problem. We slowed the titration, and within two weeks her appetite and stool were back to baseline. The lesson wasn’t chew-versus-powder. It was that even a well-absorbed precursor can look like it’s failing if you don’t respect the ramp.

Where the Evidence Gets Thin

I want to be direct about the limits here, because this is exactly where the marketing on both sides overstates its case. There is no head-to-head canine study I’m aware of that directly compares serum or plasma NAD+ metabolite levels after a chew-form dose versus a powder-form dose of the same precursor at the same milligram amount. Nearly all of the pharmacokinetic data we’re extrapolating from — including the Nicotinamide riboside is uniquely and orally bioavailable in mice and humans work and the Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults trial — comes from mice and humans, not dogs. A regulatory review from the EFSA Journal: EFSA evaluated nicotinamide riboside chloride’s safety and bioavailability as a novel food ingredient and reached favorable conclusions on human absorption, but again, that’s not canine-specific pharmacokinetic data, and it says nothing about format. Anyone telling you with confidence that chews absorb “40% faster” or citing a specific canine bioavailability percentage for one format over another is not working from a study that exists in the public literature. Treat those numbers, wherever you see them, as unverified.

What does have real support: NR and NMN are both moisture- and heat-sensitive compounds, and soft chews are manufactured with heat and moisture as part of the process. That’s a formulation-stability concern, not a gut-absorption concern, but it can functionally reduce the delivered dose in a chew if a manufacturer hasn’t validated potency through shelf life. Powder, kept dry and added at the point of feeding, sidesteps that specific risk. This is a difference in how much intact precursor survives to reach the gut, not a difference in how the gut handles it once it arrives.

The Compliance Counterargument, and Why I Still Land on Powder First

The strongest case for chews isn’t chemistry, it’s behavior. A precisely dosed powder is worthless if it sits untouched at the bottom of a bowl. I had a Cavalier owner tell me, half-laughing, that she found three weeks of powder-dusted kibble pieces spat out under the couch before she realized her dog had been sorting around it the entire time. That’s not a hypothetical failure mode; it’s the most common one I see, and it’s why some clinicians default to chews regardless of the theoretical stability edge. My honest answer: if your dog reliably eats a food-mixed topper, start with powder, because you get better lot-to-lot dosing consistency and you sidestep heat-and-moisture degradation risk. If your dog picks around powder, sorts it out, or refuses the food it’s mixed into, a well-formulated chew that a manufacturer has validated for potency through its stated shelf life is the better real-world choice — a supplement your dog will actually finish beats a theoretically superior one it won’t touch. That’s not a hedge. It’s the same principle I use for any chronic medication: the best pharmacokinetic profile on paper loses to zero milligrams delivered.

If you’re still deciding which physical format fits your household, our companion breakdown on Chew vs Powder vs Liquid Supplements for Dogs covers the mechanics of each format across supplement categories, not just NAD+ precursors. For owners weighing freeze-dried options specifically, Freeze-Dried vs Powder Supplements for Dogs is worth a read before you commit to a format.

A Practical Sequence for Choosing

Start by asking whether your dog reliably finishes a food topper without sorting through it — that answer determines more than any absorption statistic will. If yes, choose a powder from a manufacturer that discloses batch potency testing and start at the labeled titration schedule rather than jumping straight to the maintenance dose. If your dog is a picky eater or you’re managing multiple chews already, a chew is a reasonable choice, but ask the manufacturer directly whether they’ve validated NR or NMN potency at the end of shelf life, not just at manufacture. Either way, give it six to eight weeks before judging effect, and if you see GI changes in the first two weeks, suspect the titration pace before you suspect the format. Dogs juggling more than one chewable supplement often need help managing pill and chew burden day to day, and our guide on splitting multiple different supplement chews for a small dog has practical mechanics for that specific problem.

Where This Lands

Otis’s owner went with powder, mixed into his usual wet-food topper each morning, because he’s never once left food in the bowl in ten years. That’s the calculus, not a chemistry lecture. The absorption science doesn’t crown chews or powder as categorically superior inside the gut — first-pass metabolism treats both the same way once the precursor is dissolved and moving through the small intestine. The real difference lives upstream of the gut: how stable the compound stays before your dog eats it, and downstream of the gut: whether your dog eats it at all. Pick the format your dog will take consistently, buy from a company that discloses potency testing, and give the titration schedule the patience it needs before you draw conclusions about whether it’s working.